Grossman William

EDGAR CIK 0001730229

enGene Therapeutics Inc. - ENGN

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer Director
Interim Chief Medical Officer
Direct Buys
1
$10,051
5,102 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/22/2026
09/24/2026
Buy
5,102 @ $1.97
 $10,051 5,102 (100.00%) Direct